What is the recommended treatment for post‑myocardial infarction pericarditis (early pericarditis or Dressler syndrome)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Post-Myocardial Infarction Pericarditis

For early post-MI pericarditis, aspirin plus colchicine is the recommended treatment, while Dressler syndrome (late post-MI pericarditis) should be treated with the same anti-inflammatory regimen used for post-cardiac injury syndromes. 1

Early Post-Infarction Pericarditis (Days 2-3 After MI)

First-Line Treatment: Aspirin Plus Colchicine

  • Aspirin is the preferred NSAID because it increases coronary flow and has antiplatelet effects demonstrated at doses up to 1.5 g/day 1, 2
  • Dosing: Aspirin 500-1,000 mg every 6-8 hours (range 1.5-4 g/day) with gastroprotection 2
  • Add colchicine 0.5-0.6 mg once or twice daily for 3 months (dose-adjust for weight: 0.5 mg twice daily if ≥70 kg, 0.5 mg once daily if <70 kg) 2
  • Most cases are self-limited and respond well to this regimen 1, 3

Important Clinical Context

  • This complication is now rare in the primary PCI era and typically occurs only with late reperfusion or failed coronary reperfusion 1
  • Treatment is generally supportive, as most cases resolve spontaneously 1
  • Only persistent symptomatic cases require aspirin plus colchicine 1

Critical Warning Signs

  • Pericardial effusion >10 mm thickness requires urgent investigation for possible subacute rupture 1, 2
  • Two-thirds of patients with effusions >10 mm may develop tamponade or free wall rupture 1
  • Hospitalization is mandatory to observe for tamponade and adjust treatment 1, 2

Dressler Syndrome (Late Post-MI Pericarditis, 1-2 Weeks After MI)

Treatment Approach

  • Treat identically to post-cardiac injury syndromes with aspirin plus colchicine 1, 2
  • This syndrome is extremely rare (<1%) in the primary PCI era 1
  • May reflect larger infarct size and/or late reperfusion 1

Treatment Duration and Tapering

  • Continue therapy for several weeks to months, even after effusion disappears 1, 2
  • Taper aspirin gradually by 250-500 mg every 1-2 weeks only after symptoms resolve and CRP normalizes 2, 4
  • Taper one drug at a time before gradually discontinuing colchicine 2

Medications to AVOID

  • Other NSAIDs (except ibuprofen) risk thinning the infarction zone and should be avoided 1
  • Ibuprofen is acceptable if aspirin cannot be used, as it increases coronary flow 1
  • Corticosteroids should be avoided or used only for refractory symptoms because they may delay myocardial infarction healing 1, 2

Refractory Cases (Second-Line Options)

  • Corticosteroid therapy can be used for refractory symptoms only, but with extreme caution due to delayed MI healing 1, 2
  • Long-term oral corticosteroids (3-6 months) or pericardiocentesis with intrapericardial triamcinolone (300 mg/m²) are options 1, 2
  • Colchicine has been successfully used in steroid-dependent cases to facilitate steroid withdrawal 5

Prognosis and Monitoring

  • Although pericarditis is associated with larger infarct size, in-hospital and 1-year mortality are similar in patients with and without pericarditis 1
  • Early post-MI pericarditis remains a marker of larger infarct size but without independent prognostic significance 1
  • Rare complications include hemopericardium, cardiac tamponade, and constrictive pericarditis 3
  • Monitor CRP levels to guide treatment duration and assess response 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Initial Treatment for Post-Pericardiotomy Syndrome and Dressler Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Post-Myocardial Infarction Pericarditis.

Current treatment options in cardiovascular medicine, 2000

Guideline

Treatment of Post-Cardiac Surgery Pericarditis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the diagnosis and treatment for pericarditis following myocardial infarction (MI)?
What is the most effective therapy for a 65-year-old patient with low-grade fever and pleuritic chest pain two weeks after myocardial infarction (heart attack)?
Can diuretics be used to treat pericardial effusion in a patient with acute pericarditis post-myocardial infarction?
Can metoprolol (beta blocker) and lisinopril (angiotensin-converting enzyme inhibitor) be given to a patient with post-myocardial infarction (post-MI) pericarditis?
What syndrome can occur as a complication of myocardial infarction?
What antipseudomonal β‑lactam antibiotic can be used as an alternative to Zerbaxa (ceftolozane/tazobactam) in an adult with no drug allergies, normal renal function, and a suspected multidrug‑resistant gram‑negative infection?
In a patient with uncomplicated acute bacterial sinusitis, is a steroid injection indicated?
Is the acute renal deterioration in this elderly man with hypertension, type‑2 diabetes, chronic ACE‑inhibitor (enalapril) use and recent etoricoxib (COX‑2 inhibitor) therapy simply a flare of chronic kidney disease rather than drug‑induced acute kidney injury?
Can chronic kidney disease precipitate acute decompensated heart failure in an elderly man with hypertension, type‑2 diabetes, on enalapril (ACE inhibitor) and etoricoxib (COX‑2 inhibitor)?
Are restlessness, mydriasis (dilated pupils), excessive biting, and compulsive grooming indicative of rabies infection in a dog?
What is the appropriate medical management for a 45-year-old man with monthly peri‑orbital edema, a small left lower‑pole renal cyst, normal renal function, and mildly elevated alanine aminotransferase and aspartate aminotransferase?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.